Literature DB >> 12031952

Role of the insulin receptor substrate 1 and phosphatidylinositol 3-kinase signaling pathway in insulin-induced expression of sterol regulatory element binding protein 1c and glucokinase genes in rat hepatocytes.

Michihiro Matsumoto1, Wataru Ogawa, Kiyoshi Teshigawara, Hiroshi Inoue, Kazuaki Miyake, Hiroshi Sakaue, Masato Kasuga.   

Abstract

The mechanism by which insulin induces the expression of the sterol regulatory element binding protein 1c (SREBP-1c) and glucokinase genes was investigated in cultured rat hepatocytes. Overexpression of an NH(2)-terminal fragment of IRS-1 that contains the pleckstrin homology and phosphotyrosine binding domains (insulin receptor substrate-1 NH(2)-terminal fragment [IRS-1N]) inhibited insulin-induced tyrosine phosphorylation of IRS-1 as well as the association of IRS-1 with phosphatidylinositol (PI) 3-kinase activity, whereas the tyrosine phosphorylation of IRS-2 and its association with PI 3-kinase activity were slightly enhanced. The equivalent fragment of IRS-2 (IRS-2N) prevented insulin-induced tyrosine phosphorylation of both IRS-1 and IRS-2, although that of IRS-1 was inhibited more efficiently. The insulin-induced increases in the abundance of SREBP-1c and glucokinase mRNAs, both of which were sensitive to a dominant-negative mutant of PI 3-kinase, were blocked in cells in which the insulin-induced tyrosine phosphorylation of IRS-1 was inhibited by IRS-1N or IRS-2N. A dominant-negative mutant of Akt enhanced insulin-induced tyrosine phosphorylation of IRS-1 (but not that of IRS-2) and its association with PI 3-kinase activity, suggesting that Akt contributes to negative feedback regulation of IRS-1. The Akt mutant also promoted the effects of insulin on the accumulation of SREBP-1c and glucokinase mRNAs. These results suggest that the IRS-1-PI 3-kinase pathway is essential for insulin-induced expression of SREBP-1c and glucokinase genes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12031952     DOI: 10.2337/diabetes.51.6.1672

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  42 in total

1.  From gallstones to genes: two hundred years of sterol research. A tribute to George J. Schroepfer Jr.

Authors:  Geoffrey F Gibbons
Journal:  Lipids       Date:  2002-12       Impact factor: 1.880

2.  Hyperinsulinemia, glucose intolerance, and dyslipidemia induced by acute inhibition of phosphoinositide 3-kinase signaling in the liver.

Authors:  Kazuaki Miyake; Wataru Ogawa; Michihiro Matsumoto; Takehiro Nakamura; Hiroshi Sakaue; Masato Kasuga
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

Review 3.  New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c.

Authors:  Fabienne Foufelle; Pascal Ferré
Journal:  Biochem J       Date:  2002-09-01       Impact factor: 3.857

4.  Functional development of the mammary gland: use of expression profiling and trajectory clustering to reveal changes in gene expression during pregnancy, lactation, and involution.

Authors:  Michael C Rudolph; James L McManaman; Larry Hunter; Tzulip Phang; Margaret C Neville
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-07       Impact factor: 2.673

5.  Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism.

Authors:  Cullen M Taniguchi; Kohjiro Ueki; Ronald Kahn
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

6.  Ancient Wheat Diet Delays Diabetes Development in a Type 2 Diabetes Animal Model.

Authors:  Anne Cathrine Thorup; Søren Gregersen; Per Bendix Jeppesen
Journal:  Rev Diabet Stud       Date:  2015-02-10

7.  CITED2 links hormonal signaling to PGC-1α acetylation in the regulation of gluconeogenesis.

Authors:  Mashito Sakai; Michihiro Matsumoto; Tomoko Tujimura; Cao Yongheng; Tetsuya Noguchi; Kenjiro Inagaki; Hiroshi Inoue; Tetsuya Hosooka; Kazuo Takazawa; Yoshiaki Kido; Kazuki Yasuda; Ryuji Hiramatsu; Yasushi Matsuki; Masato Kasuga
Journal:  Nat Med       Date:  2012-03-18       Impact factor: 53.440

8.  Fibroblast growth factor-19, a novel factor that inhibits hepatic fatty acid synthesis.

Authors:  Sushant Bhatnagar; Holly A Damron; F Bradley Hillgartner
Journal:  J Biol Chem       Date:  2009-02-20       Impact factor: 5.157

9.  PKClambda in liver mediates insulin-induced SREBP-1c expression and determines both hepatic lipid content and overall insulin sensitivity.

Authors:  Michihiro Matsumoto; Wataru Ogawa; Kazunori Akimoto; Hiroshi Inoue; Kazuaki Miyake; Kensuke Furukawa; Yoshitake Hayashi; Haruhisa Iguchi; Yasushi Matsuki; Ryuji Hiramatsu; Hitoshi Shimano; Nobuhiro Yamada; Shigeo Ohno; Masato Kasuga; Tetsuo Noda
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

Review 10.  Molecular physiology of mammalian glucokinase.

Authors:  P B Iynedjian
Journal:  Cell Mol Life Sci       Date:  2009-01       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.